Ozempic Shows Promise Treating Kidney Failure in Blow to Dialysis Firms

(Bloomberg) -- Novo Nordisk A/S diabetes drug Ozempic showed surprisingly early effectiveness in a kidney-failure study, sending shares of the world’s biggest dialysis providers tumbling.Most Read from BloombergIsrael Latest: Sirens Sound in North, Biden Speaks to NetanyahuIsrael Latest: Israeli Death Toll in Hamas Attack Reaches 1,200Israel Forms Emergency Government for War Against HamasHamas Got Around Israel’s Surveillance Prowess by Going DarkIMF Caught Off Guard as China Strikes Sri Lanka

Related Keywords

Copenhagen ,Køavn ,Denmark ,New York ,United States ,Germany ,Bad Homburg ,Hessen ,German ,Danish ,John Lauerman ,Tim Loh ,Joshua Gallu ,Bloomberg Novo Nordisk ,Veronika Dubajova ,Michael Sen ,Bloomberg Businessweek ,Davita Inc ,Bloomberg ,Fresenius Medical ,Fresenius Medical Care Ag Co ,Baxter International Inc ,Walmart Inc ,Eli Lilly Co ,Citigroup Inc ,Fresenius ,Jefferies Financial Group Inc ,Fresenius Medical Care ,Eli Lilly ,Germany Based Fresenius Medical ,Jefferies Financial Group ,All About ,New Obesity Drugs Causing ,Big Stir ,Fresenius Medical Care Ag ,Kidney Disease ,Ozempic ,